- Home
- AZZ vs XENE Comparison
AZZ vs XENE Comparison
Compare AZZ & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- XENE
- Stock Information
- Founded
- AZZ 1956
- XENE 1996
- Country
- AZZ United States
- XENE Canada
- Employees
- AZZ N/A
- XENE N/A
- Industry
- AZZ Industrial Specialties
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- AZZ Industrials
- XENE Health Care
- Exchange
- AZZ Nasdaq
- XENE Nasdaq
- Market Cap
- AZZ 2.7B
- XENE 2.4B
- IPO Year
- AZZ N/A
- XENE 2014
- Fundamental
- Price
- AZZ $106.42
- XENE $32.21
- Analyst Decision
- AZZ Buy
- XENE Strong Buy
- Analyst Count
- AZZ 7
- XENE 11
- Target Price
- AZZ $108.00
- XENE $54.82
- AVG Volume (30 Days)
- AZZ 310.7K
- XENE 1.5M
- Earning Date
- AZZ 07-09-2025
- XENE 08-07-2025
- Dividend Yield
- AZZ 0.64%
- XENE N/A
- EPS Growth
- AZZ 908.98
- XENE N/A
- EPS
- AZZ 8.62
- XENE N/A
- Revenue
- AZZ $1,586,498,000.00
- XENE $7,500,000.00
- Revenue This Year
- AZZ $8.32
- XENE N/A
- Revenue Next Year
- AZZ $2.57
- XENE $253.71
- P/E Ratio
- AZZ $12.31
- XENE N/A
- Revenue Growth
- AZZ 1.70
- XENE N/A
- 52 Week Low
- AZZ $69.59
- XENE $26.74
- 52 Week High
- AZZ $113.58
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- AZZ 78.16
- XENE 50.43
- Support Level
- AZZ $98.26
- XENE $31.22
- Resistance Level
- AZZ $113.58
- XENE $33.51
- Average True Range (ATR)
- AZZ 3.02
- XENE 1.24
- MACD
- AZZ 1.28
- XENE 0.06
- Stochastic Oscillator
- AZZ 73.62
- XENE 40.88
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.